Introduction to Semanat Injection (Semaglutide) 1.1 Overview of Semaglutide as a GLP-1 Receptor Agonist Semanat Injection contains semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist engineered to emulate endogenous incretin hormones
Its FDA-cleared for treating insomnia and is believed to work by improving brain function
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Dhurandhar E.J., Maki K.C., Dhurandhar N.V., Kyle T.K., Yurkow S., Hawkins M.A.W., Agley J., Ho E.H., Cheskin L.J., Sorensen T.I.A., Wang X.R., Gorman B., Allison D.B
GLP-1 therapy belongs to a class of medications called glucagon-like peptide-1 (GLP-1) agonists
Here are common questions to help clarify what sets each program apart